Sign In

Login

Password

Forgot Password ? Sign Up

アルトレタミン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "アルトレタミン" in Japanese language version.

refsWebsite
Global rank Japanese rank
6nih.gov
4th place
24th place
5doi.org
2nd place
6th place
1drugs.com
399th place
1,603rd place

doi.org

  • “Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study”. Gynecol. Oncol. 88 (2): 118–22. (2003). doi:10.1016/S0090-8258(02)00103-8. PMID 12586589. 
  • “Oral altretamine used as salvage therapy in recurrent ovarian cancer”. Gynecol. Oncol. 92 (1): 368–71. (2004). doi:10.1016/j.ygyno.2003.09.017. PMID 14751188. 
  • Malik IA (2001). “Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer”. Jpn. J. Clin. Oncol. 31 (2): 69–73. doi:10.1093/jjco/hye012. PMID 11302345. 
  • “Clinical pharmacokinetics of altretamine”. Clinical Pharmacokinetics 28 (6): 439–48. (1995). doi:10.2165/00003088-199528060-00002. PMID 7656502. 
  • Wiernik, P. H.; Yeap, B.; Vogl, S. E.; Kaplan, B. H.; Comis, R. L.; Falkson, G.; Davis, T. E.; Fazzini, E. et al. (1992). “Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: A study of the Eastern Cooperative Oncology Group”. Cancer Investigation 10 (1): 1–9. doi:10.3109/07357909209032783. PMID 1735009. 

drugs.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • “Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study”. Gynecol. Oncol. 88 (2): 118–22. (2003). doi:10.1016/S0090-8258(02)00103-8. PMID 12586589. 
  • “Oral altretamine used as salvage therapy in recurrent ovarian cancer”. Gynecol. Oncol. 92 (1): 368–71. (2004). doi:10.1016/j.ygyno.2003.09.017. PMID 14751188. 
  • Malik IA (2001). “Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer”. Jpn. J. Clin. Oncol. 31 (2): 69–73. doi:10.1093/jjco/hye012. PMID 11302345. 
  • “Clinical pharmacokinetics of altretamine”. Clinical Pharmacokinetics 28 (6): 439–48. (1995). doi:10.2165/00003088-199528060-00002. PMID 7656502. 
  • Wiernik, P. H.; Yeap, B.; Vogl, S. E.; Kaplan, B. H.; Comis, R. L.; Falkson, G.; Davis, T. E.; Fazzini, E. et al. (1992). “Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: A study of the Eastern Cooperative Oncology Group”. Cancer Investigation 10 (1): 1–9. doi:10.3109/07357909209032783. PMID 1735009. 

dailymed.nlm.nih.gov